EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monocyte/Macrophage-Specific Loss of ARNTL Suppresses Chronic Kidney Disease-Associated Cardiac Impairment

Yuya Yoshida iD, Naoki Nishikawa, Kohei Fukuoka iD, Akito Tsuruta iD, Kaita Otsuki, Taiki Fukuda, Yuma Terada, Tomohito Tanihara, Taisei Kumamoto, Ryotaro Tsukamoto, Takumi Nishi, Kosuke Oyama iD und 5 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252313009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yuya Yoshida und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Hauptthemen laut MEDLINE: ARNTL Transcription Factors, Monocytes, Renal Insufficiency, Chronic, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defects in Aryl hydrocarbon receptor nuclear translocator-like 1 (ARNTL), a central component of the circadian clock mechanism, may promote or inhibit the induction of inflammation by monocytes/macrophages, with varying effects on different diseases. However, ARNTL’s role in monocytes/macrophages under chronic kidney disease (CKD), which presents with systemic inflammation, is unclear. Here, we report that the expression of Arntl in monocytes promoted CKD-induced cardiac damage. The expression of G-protein-coupled receptor 68 (GPR68), which exacerbates CKD-induced cardiac disease, was regulated by ARNTL. Under CKD conditions, GPR68 expression was elevated via ARNTL, particularly in the presence of PU.1, a transcription factor specific to monocytes and macrophages. In CKD mouse models lacking monocyte-specific ARNTL, GPR68 expression in monocytes was reduced, leading to decreased cardiac damage and fibrosis despite no improvement in renal excretory capacity or renal fibrosis and increased angiotensin II production. The loss of ARNTL did not affect the expression of marker molecules, indicating the origin or differentiation of cardiac macrophages, but affected GPR68 expression only in cardiac macrophages derived from mature monocytes, highlighting the significance of the interplay between GPR68 and ARNTL in monocytes/macrophages and its influence on cardiac pathology. Understanding this complex relationship between circadian clock mechanisms and disease could help uncover novel therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ARNTL Transcription FactorsMonocytesRenal Insufficiency, ChronicMacrophagesAnimalsMiceReceptors, G-Protein-CoupledDisease Models, AnimalMaleHeart DiseasesMice, Inbred C57BLHumansMice, Knockout

Stichwörter der Autor:innen

ARNTLcardiac pathology GPR68chronic kidney diseasecircadian clock mechanism

Substanzen

ARNTL Transcription FactorsReceptors, G-Protein-CoupledBmal1 protein, mouse

Autor:innen und Institutionen

  • Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Biological Science and Technology, Faculty of Advanced Engineering, Tokyo University of Science, 1-3 Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan.
  • Department of Drug Discovery Structural Biology, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

ORCID-Profile: Yuya Yoshida, Kohei Fukuoka, Akito Tsuruta, Kosuke Oyama, Kengo Hamamura, Naoya Matsunaga

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development
  • Basis for Supporting Innovative Drug Discovery and Life Science Research

Zitieren

APA

Yoshida, Y., Nishikawa, N., Fukuoka, K., Tsuruta, A., Otsuki, K., Fukuda, T., Terada, Y., Tanihara, T., Kumamoto, T., Tsukamoto, R., Nishi, T., Oyama, K., Hamamura, K., Mayanagi, K., Koyanagi, S., Ohdo, S., & Matsunaga, N. (2024). Monocyte/Macrophage-Specific Loss of ARNTL Suppresses Chronic Kidney Disease-Associated Cardiac Impairment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313009

Vancouver

Yoshida Y, Nishikawa N, Fukuoka K, Tsuruta A, Otsuki K, Fukuda T, et al. Monocyte/Macrophage-Specific Loss of ARNTL Suppresses Chronic Kidney Disease-Associated Cardiac Impairment. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313009

BibTeX
@article{Yoshida2024,
  author = {Yoshida, Yuya and Nishikawa, Naoki and Fukuoka, Kohei and Tsuruta, Akito and Otsuki, Kaita and Fukuda, Taiki and Terada, Yuma and Tanihara, Tomohito and Kumamoto, Taisei and Tsukamoto, Ryotaro and Nishi, Takumi and Oyama, Kosuke and Hamamura, Kengo and Mayanagi, Kouta and Koyanagi, Satoru and Ohdo, Shigehiro and Matsunaga, Naoya},
  title = {Monocyte/Macrophage-Specific Loss of ARNTL Suppresses Chronic Kidney Disease-Associated Cardiac Impairment},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252313009}
}
Kostenlos starten →